Authors:
MARSHALL JL
WELLSTEIN A
RAE J
DELAP RJ
PHIPPS K
HANFELT J
YUNMBAM MK
SUN JX
DUCHIN KL
HAWKINS MJ
Citation: Jl. Marshall et al., PHASE-I TRIAL OF ORALLY-ADMINISTERED PENTOSAN POLYSULFATE IN PATIENTSWITH ADVANCED CANCER, Clinical cancer research, 3(12), 1997, pp. 2347-2354
Authors:
ZHOU XJ
SQUIRES K
PANZHOU XR
BERNHARD S
AGROFOGLIO L
KIRK M
DUCHIN KL
SOMMADOSSI JP
Citation: Xj. Zhou et al., PHASE-I DOSE-ESCALATION PHARMACOKINETICS OF AZT-P-DDI (IVX-E-59) IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Journal of clinical pharmacology, 37(3), 1997, pp. 201-213
Authors:
ZHOU XJ
SQUIRES K
BERNHARD S
DELOACH L
DUCHIN KL
SOMMADOSSI JP
Citation: Xj. Zhou et al., DOSE-ESCALATING PHARMACOKINETICS OF AZT-P-DDI (IVX-E-59) AFTER SHORT-TERM INTRAVENOUS-INFUSION AND ORAL-ADMINISTRATION IN HIV-INFECTED PATIENTS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 103-103
Citation: Twb. Gehr et al., THE PHARMACOKINETICS AND PHARMACODYNAMICS OF FOSINOPRIL IN HEMODIALYSIS-PATIENTS, European Journal of Clinical Pharmacology, 45(5), 1993, pp. 431-436